Suturegard

Portland, United States Founded: 2015 • Age: 11 yrs
Wound closure devices for skin are manufactured by Suturegard.
Annual revenue - Latest available
Total funding $580,000 3 rounds
Employees - Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About Suturegard

Suturegard is a company based in Portland (United States) founded in 2015 by Jen Akeroyd and Bill Lear. Suturegard has raised $580 thousand across 3 funding rounds. Suturegard operates in a competitive market with competitors including Adhezion Biomedical, Inno Therapy, HyperBranch Medical, BRIJ Medical and Limax Biosciences, among others.

  • Headquarter Portland, United States
  • Founders Jen Akeroyd, Bill Lear
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Suturegard Medical, Inc
Operational Areas
Healthcare → Medical Devices & Diagnostics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $580 K (USD)

    in 3 rounds

  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Suturegard

Suturegard has successfully raised a total of $580K across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investments & Acquisitions by Suturegard

Investments
Premium access

Investment portfolio details for Suturegard

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Suturegard

Premium access

Detailed financials for Suturegard

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Suturegard Comparisons

Suturegard Primary company
Description
Wound closure devices for skin are manufactured by Suturegar...
Location
Portland, United States
Founded Year
2015
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Suturegard

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Suturegard

Suturegard operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Adhezion Biomedical, Inno Therapy, HyperBranch Medical, BRIJ Medical and Limax Biosciences, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Developer of cyanoacrylate based surgical, wound management, and infection prevention products
Locked Locked Locked
Hemostatic polymers are produced for surgical and wound care applications.
Locked Locked Locked
Biosurgical devices are developed using proprietary polymers and hydrogels.
Locked Locked Locked
Medical devices for post-surgical and trauma incision care are provided.
Locked Locked Locked
Stretchable hydrogel adhesives are developed for wound sealing and healing.
Premium access

Detailed competitors of Suturegard

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Suturegard

Premium access

Complete news archive for Suturegard

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Suturegard

Suturegard was founded in 2015 and raised its 1st funding round 6 years after it was founded.

Suturegard is headquartered in Portland, United States. It is registered at Portland, Oregon, United States.

Dan Ladizinsky is the current CEO of Suturegard.

Suturegard is a funded company, having raised a total of $580K across 3 funding rounds to date.

Suturegard was founded in 2015 in Portland, United States, within the medical devices sector. Devices for wound closure are produced, including SutureGard, which pre-stretches skin prior to closure or serves as an alternative to skin flaps, grafts, or secondary intention healing. HemiGard is offered as an adhesive retention suture device designed for fragile skin wounds to prevent tearing during closure. Operations focus on manufacturing these products for surgical applications.

Suturegard's top competitors include Adhezion Biomedical, BRIJ Medical and Inno Therapy.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available